DRIVING FORWARD
HAEMATOLOGY RESEARCH 2021 saw the renewed focus on expanding Icon’s haematology clinical trials program with the appointment of a dedicated Research Portfolio Lead, Yvette James. Yvette brings in-depth experience in oncology and haematology nursing as well as knowledge of trial management. With a dedicated resource working with the Haematology Research Clinical Lead, Dr Jason Butler, and alongside a recently established Haematology Research Committee, the haematology portfolio continues to mature. Future focus will see the strengthening of current and new commercial and non-commercial sponsors, including our ongoing relationship with the Australasian Leukaemia and Lymphoma Group (ALLG). A renewed focus on internal promotion of Icon’s haematology expertise will also contribute to increased opportunities for research and registry involvement across Australia and beyond.
20
ICON ANNUAL RESEARCH REPORT 2021
